Stynes, Gillian <br/><br/>
Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.  [electronic resource] 

 -  Respiratory research  Feb 2015 
 - 25 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1465-993X 
<br/><br/><label>Standard No.: </label>10.1186/s12931-015-0184-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Aged<br/>Androstadienes--administration & dosage<br/>Bayes Theorem<br/>Benzyl Alcohols--administration & dosage<br/>Bronchodilator Agents--administration & dosage<br/>Budesonide, Formoterol Fumarate Drug Combination--administration & dosage<br/>Chlorobenzenes--administration & dosage<br/>Disease Progression<br/>Drug Administration Schedule<br/>Female<br/>Fluticasone-Salmeterol Drug Combination--administration & dosage<br/>Forced Expiratory Volume<br/>Humans<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Randomized Controlled Trials as Topic<br/>Recovery of Function<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome